Novocure (NVCR) Misses Q4 EPS by 25c
Tweet
Share
E-mailGet Alerts NVCR Hot Sheet
Join SI Premium – FREE
Novocure (NASDAQ: NVCR) reported Q4 EPS of ($0.61), $0.25 worse than the analyst estimate of ($0.36). Revenue for the quarter came in at $161.26 million versus the consensus estimate of $153.04 million.
For earnings history and earnings-related data on Novocure (NVCR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Berenberg Starts Brooks Macdonald Group PLC (BRK:LN) at Buy
- Morgan Stanley Resumes OMV AG (OMV:AV) (OMVKY) at Equalweight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
